Targeting inflammation may help overcome drug resistance in colon cancer
Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. According to a new preclinical study by Weill Cornell Medicine and MD Anderson ...
21 May 15:00 · Medical Xpress